EXoZymes Inc (EXOZ)
eXoZymes Inc. is a development-stage biotechnology company listed on the NASDAQ under the ticker EXOZ. The company focuses on developing enzyme modules and cell-free exozyme biosolutions for use in synthetic biology manufacturing. Founded in 2014 and headquartered in Monrovia, California, the company previously operated under the name Invizyne Technologies, Inc. before adopting its current name in February 2025. As common stock, NASDAQ-EXOZ represents equity in the company rather than a fund, debt instrument, or other specialized security.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-EXOZ
|
$3.29
|
-48.9% Downside
|
Overvalued
|
Not available
|
Not available
|
Weak
|
0.0%
|
November 12, 2026
|
16.4x
|
59.726 M
|
55.204 M
|
1.7%
|
77.2%
|
0.3
|
70.1%
|
